CONTINUING MEDICAL EDUCATION (CME) QUESTIONS|
May 20, 2021
Prognosis of comutations in IDH1/2-mutated AML
CME
Blood (2021) 137 (20): 2856.
Article history
First Edition:
April 8, 2021
Connected Content
A related article has been published:
Prognostic significance of concurrent gene mutations in intensively treated patients with IDH-mutated AML: an ALFA study
Citation
Prognosis of comutations in IDH1/2-mutated AML. Blood 2021; 137 (20): 2856. doi: https://doi.org/10.1182/blood.2021012066
Download citation file: